spacer
home > ict > autumn 2016 > future vision
PUBLICATIONS
International Clinical Trials

Future Vision

Over the past few years, certain factors have contributed to a rising trend of trial supply sourcing: an increase of studies being conducted, reduced start-up timelines, patient recruitment issues, globalisation and the escalating costs for investigational drugs and comparators. Is it even possible to predict the precise number of supplies needed to run a trial efficiently?

Looking Ahead


One option may be the use of forecasting and simulations. Consider a weather forecast, for instance: weathermen will predict high and low temperatures, humidity level, air pressure and other elements based on a number of factors. Different weather models will generally produce similar – but not identical – predictions, shown by minor variations in forecasts from different weather stations. Also, as you look further into the future, the predictions of each model will vary more and reliability will be reduced. This is why, if you are anticipating an event, it is necessary to check weather forecasts regularly as the day of the event approaches.

This is also the case with trial supply forecasts. Forecasting refers to techniques used to predict future outcomes, on the basis of past events and professional insights gained from observation. Methods usually rely on mathematical formulas based on facts, perceived trends, data models and, at times, expert opinions. While it is impossible to know the results of a clinical trial ahead of time with absolute certainty, forecasting provides sponsors with data-driven decisions when planning, running and closing a study.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer
Praveen Chand is the Director of Professional Services and Clinical Analytics at Cenduit. He brings over 15 years of technology consulting and innovations experience, with a primary focus on pharma and life sciences translational research in clinical trials and drug development. Praveen holds an MS in Computer Science and Engineering, and a BS in Electronics and Instrumentation from GJ University of Science and Technology in Hisar, India.
spacer
Praveen Chand
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Huge boom in Korean Pharma reported at CPhI Korea

Amsterdam, 19th September 2019: The recently-closed CPhI Korea – co-organised by Informa Markets and the Korea Pharmaceutical Traders Association (KPTA) – has seen a surge in growth across domestic and international pharma companies, as well as a sizable rise in overall attendees. As reported earlier this year in the provisional findings of the CPhI Pharma Index[1], Korea has seen a rapid growth in its international reputation (seeing its ‘overall competitiveness’ rise 14% in the last two years), which is now translating into a sizable growth in the market and at the event.
More info >>

White Papers

7 Common Myths about QP Training Debunked: A Guide for Senior Managers

RSSL

The role of the Qualified Person (QP) in the pharmaceutical industry is mandated by law (Directive 2001/83/EC, Directive 2001/20/EC, UK SI 2012/1916, UK SI 2004/103). Every holder of a relevant Manufacturers Authorisation (human and veterinary) must have at least one QP; without one, no batch of medicinal product can be certified for release for sale.
More info >>

 
Industry Events

World Vaccine Congress Washington

27-29 September 2020, Walter E Washington Convention Center, Washington, US

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement